PolyNovo Past Earnings Performance

Past criteria checks 3/6

PolyNovo has been growing earnings at an average annual rate of 29.2%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 37.1% per year. PolyNovo's return on equity is 7.3%, and it has net margins of 5.1%.

Key information

29.2%

Earnings growth rate

29.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate37.1%
Return on equity7.3%
Net Margin5.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How PolyNovo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CALZ.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241035810
31 Mar 24933740
31 Dec 23832690
30 Sep 2375-2630
30 Jun 2366-5550
31 Mar 2359-6510
31 Dec 2253-7470
30 Sep 2248-4390
30 Jun 2242-1320
31 Mar 22380290
31 Dec 21351260
30 Sep 2132-2270
30 Jun 2129-5270
31 Mar 2127-5260
31 Dec 2025-5250
30 Sep 2024-5230
30 Jun 2022-4210
31 Mar 2020-4190
31 Dec 1918-4170
30 Sep 1916-3150
30 Jun 1914-3120
31 Mar 1912-4110
31 Dec 189-590
30 Sep 188-590
30 Jun 187-680
31 Mar 186-680
31 Dec 175-680
30 Sep 174-680
30 Jun 174-570
31 Mar 174-460
31 Dec 165-350
30 Sep 164-350
30 Jun 163-350
31 Mar 162-340
31 Dec 150-240
30 Sep 150-230
30 Jun 150-130
31 Mar 150-230
31 Dec 140-330
30 Sep 140-330
30 Jun 140-330
31 Mar 140-230
31 Dec 130-220

Quality Earnings: CALZ.F has high quality earnings.

Growing Profit Margin: CALZ.F became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CALZ.F has become profitable over the past 5 years, growing earnings by 29.2% per year.

Accelerating Growth: CALZ.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CALZ.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: CALZ.F's Return on Equity (7.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies